Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/13/02 → 2/28/07 |
Funding
- Merck and Company Inc: $42,434.00
A Randomized Double-Blind Active-Comparator-ontrolled Parallel Group Study to Evaluate the Safety of Etoricoxib in Osteoarthritis or Rheumatoid Arthritis
- Caudill, Timothy (PI)